0001415889-24-011764.txt : 20240430 0001415889-24-011764.hdr.sgml : 20240430 20240430163530 ACCESSION NUMBER: 0001415889-24-011764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240426 FILED AS OF DATE: 20240430 DATE AS OF CHANGE: 20240430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ragosa Mark CENTRAL INDEX KEY: 0001835458 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 24897878 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS CORP. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4-04302024_080421.xml X0508 4 2024-04-26 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001835458 Ragosa Mark C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 BERMUDA false true false false CHIEF FINANCIAL OFFICER 0 Class A Common Share 2024-04-26 4 M 0 991 A 19762 D Class A Common Share 2024-04-26 4 F 0 509 17.88 D 19253 D Restricted Share Unit 2024-04-26 4 M 0 991 0 A Class A Common Share 991 990 D Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 26, 2021. /s/ Madelyn Zeylikman, Attorney-in-Fact 2024-04-30